retatrutide and heart health Side Effects Guide: 21 Proven Remedies That Work Retatrutide: What We Know About

Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension

This is the most common complaint in patient surveys about GLP-1 access (Luo et al., JAMA Network Open 2024)

Research suggests that even sub-therapeutic doses from a weight loss perspective produce measurable reductions in circulating IL-6 and TNF-alpha

Supplements are not a replacement for nutrient-dense meals, but they can make it easier to maintain more consistent nutrition while adjusting to lower appetite and changing eating patterns on GLP-1 medications

Nausea, vomiting, diarrhea, and constipation occur in 2050% of patients, though symptoms are typically mild to moderate and diminish over time

GLP-1 medications have been shown to help people lose a significant percentage of body weight when paired with a healthy diet and regular exercise